"If you want big pharma exposure, with fewer headaches related to U.S. politics, you could always buy a well-run foreign drug company," he said, because they are not so dependent on the American market.of the improving presidential prospects of Sen. Elizabeth Warren, D-Mass. They trimmed their holdings in the sector over Warren's uncertain chances of getting lawmakers to pass a national health-care policy that would upend the U.S. health-care system.
The drugmaker also has a number of cancer-fighting products in the pipeline that can contribute to its growth. "I'm even more bullish about GlaxoSmithKline than I was in January," Cramer said. "With the stock selling for less than 14 times earnings, I'm calling it a steal. Plus, [CEO Emma] Walmsley's paying you to wait: 4.8% yield. That's a good investment."
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »